The United States The Bureau of Patents and Brands rejected the Atample of Neuralink to mark the names of telepathy and telekinesis products, applications awaiting the city by another person for the same brands.

Neuralink, the brain establishment co -founded by Elon Musk, has filed a brand to mark the names in March. But in the letters sent to Neuralink in August, the brand office refuses to allow the request to move forward. He indicates that Wesley Berry, a computer scientist and co -founder of the prophetic technological startup, previously filed telepathy requests in May 2023 and telekinesis in August 2024 brand applications, and not prophetic. (Berry refused to comment on this story.)

In response to Neuralink’s telepathy demand, the brand office also refers to the existing brand for telepathy laboratories, in the company based in Tampa which provides voice and interactive chatbot technology to businesses.

The Musk neuralink, on the other hand, develops a brain interface that involves a device, surgically implands in the skull, which collects brain activity. The company used the name of telepathy to disconcert its first product, which is designed to make people paralyze the competence to work their phones and computers with just their thoughts. Musk unveiled the name of telepathy in January 2024 Social media messageShortly after the company set up its first volunteer with technology. A total of nine now the neural system, according to a July announcement. (Neuralink did not respond to a request for comments.)

Berry and Neuralink have filed requests “entirely for use”, which alllaw commercial and inventors to reserve the rights of the brand before the trademark. Berry’s request for telepathy was Accepted in December 2024 And for telekinesis In August 2025 But the brands are not entirely recorded until it shows that it really uses them in the trade. Berry has three years to do so by acceptance, otherwise his requests would be considered abandoned and the request of Neuralink would be a priority.

Berry has not marketed or marketed a product called telepathy or telekinesis, but in its brand applications describes both “software that analyzes EEG to decode internal dialogue to control computer or mobile devices”. EEG, or electroencephalogram, the data refer to the electrical activity of the brain recorded by electrodes carried on the scalp.

The letters of the brand’s office in Neuralink are not final decisions. Neuralink filed a letter of response on August 28 concerning the existing brand of telepathy laboratories, saying that the Neuralink telepathy product will not be likely to be confused with telepathy laboratories. Neuralink did not address Berry’s applications in his response.

“The standard for the probability of confusion is that if a random consumer encountered these two products, would they think that in the same company?” Said Heather Antoine, partner of intellectual property property at Stoel Care in Sacramento, California.

The brand’s office will examine Neuralink’s response and decide if there is a probability of confusion. But there is always the fact that Berry has filed a file to record the notes of telepathy and telekinesis first. If Berry succeeds in recording the brands, Neuralink would have some options. He managed to buy the Berry brands or negotiate a concentration agreement, in which Berry COULING accepts Allaw Neuralink to also use brands. These types of agreements are generally concluded when brands are not likely to cause consumers’ confusion.

If Berry is later in the recording of telepathy, the neural brooding is continued if the company continues to use it.

Josh Gerben, in the brand’s lawyer and founder of Gerben IP in Washington, DC, says it is difficult to know how things will shake because there are a lot of nuances in a brand complaint. “Certainly for the moment, however, the advantage goes to this other application,” he said, referring to Berry. “He could become a consoled spine in the side of Neuralink in terms of these marks.”